Molecular Therapy: Oncology
Издатель: Elsevier · ISSN 2950-3299 · 91 статей
- Mechanisms of resistance to BTK inhibitors in B cell malignancies and emerging targeted strategies
- Pediatric AML CAR T cell therapy
- Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision
- Short-chain fatty acids act as metabolic and epigenetic regulators in CAR T cell therapy
- Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer
- Hydrogel-based lineage-specific gene therapy prevents recurrence of corticotroph tumors
- Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC
- A tri-component organoid model reveals field-cancerized fibroblasts as key drivers of LUAD recurrence and drug resistance
- Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids
- Development of chimeric antigen receptors targeting the γδ T cell receptor
- Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity
- PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells
- Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell response
- Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis
- Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZ
- Augmenting CAR T cell functionality and metabolism through CD39 downtuning
- Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings
- Oncolytic adenoviruses AdNuPAR armed with PDT activate nucleoside prodrugs to induce bystander killing and trigger anticancer effects
- Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies
- Comparative evaluation of oncolytic viruses reveals opposing preferences for glioblastoma subtypes
- A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia
- Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses
- Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant
- Preclinical study of an optimized AAV cancer vaccine in a spontaneous canine model of oral melanoma
- Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids
- Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy
- Oncolytic virus-mediated remodeling of tumor microenvironment enhances efficacy of an HPV16 E6/E7 mRNA vaccine in an HPV-positive tumor
- Oncolytic virotherapy with chimeric rVSV-NDV causes tumor-specific immunity in a DC-activation-dependent manner
- Lnk Governs chemokine-directed trafficking of CD8+ T cells in melanoma
- Angiopoietin-like protein 4 deficiency promotes tumor immune infiltration and CD8+ T cell cytotoxic activity to inhibit tumor progression